Update on biology and treatment of T-cell acute lymphoblastic leukaemia
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pediatrics, Perinatology, and Child Health
Reference39 articles.
1. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.;Vora;Lancet Oncol,2013
2. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.;Schrappe;Blood,2011
3. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.;Conter;Blood,2010
4. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.;Rivera;Cancer,2005
5. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Childrens Cancer Group (CCG).;Kees;Leukemia,2003
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cytogenomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals TCR rearrangements as predictive factors for exceptional prognosis;Molecular Cytogenetics;2024-05-23
2. Development of second genetically distinct T‐lymphoblastic leukemia in a pediatric patient;Pediatric Blood & Cancer;2024-05-12
3. Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities;Diagnostics;2023-08-24
4. Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia;Frontiers in Immunology;2023-05-17
5. Inhibition of Integrin α v β 3 -FAK-MAPK signaling constrains the invasion of T-ALL cells;Cell Adhesion & Migration;2023-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3